Sila Realty Trust, Inc.
SILASila Realty Trust, Inc. (SILA) is a real estate investment trust focused on the acquisition, development, and management of retail properties across the United States. The company primarily owns grocery-anchored shopping centers and community centers, aiming to provide stable income and long-term growth through its diversified portfolio of retail assets.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| June 4, 2026 | $0.40 | 2026-05-20 | 2026-05-20 |
| March 18, 2026 | $0.40 | 2026-03-06 | 2026-03-06 |
| December 4, 2025 | $0.40 | 2025-11-20 | 2025-11-20 |
| September 4, 2025 | $0.40 | 2025-08-21 | 2025-08-21 |
| June 4, 2025 | $0.40 | 2025-05-21 | 2025-05-21 |
Dividends Summary
- Consistent Payer: Sila Realty Trust, Inc. has rewarded shareholders with 12 dividend payments over the past 2 years.
- Total Returned Value: Investors who held SILA shares during this period received a total of $3.20 per share in dividend income.
- Latest Payout: The most recent dividend of $0.40/share was paid 44 days ago, on June 4, 2026.
- Yield & Schedule: SILA currently pays dividends quarterly with an annual yield of 5.27%.
- Dividend Growth: Since 2024, the dividend payout has grown by 200.1%, from $0.13 to $0.40.
- Dividend Reliability: SILA has maintained or increased its dividend for 12 consecutive payments.
Company News
Law firm Brodsky & Smith has initiated investigations into four merger transactions, examining whether the boards of KalVista Pharmaceuticals, Thermon Group Holdings, Sila Realty Trust, and Lisata Therapeutics breached fiduciary duties by failing to conduct fair processes and potentially underpaying shareholders. The deals range in value from app...
Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential violations of federal securities laws and breaches of fiduciary duties. The investigations concern Sila Realty Trust's sale to Blue Owl affiliates, Esperion Therapeutics' sale to ARCHIMED funds, and a merger between Corebridge Financial and Equitable Hold...
Law firm Brodsky & Smith announced investigations into four merger transactions, examining whether company boards breached fiduciary duties by failing to conduct fair processes and ensure fair value for shareholders. The investigations involve Esperion Therapeutics (ARCHIMED acquisition at $3.16/share), Sila Realty Trust (Blue Owl Capital acquisi...
Halper Sadeh LLC, an investor rights law firm, is investigating Sila Realty Trust's $30.38 per share sale to Blue Owl Real Estate Capital affiliates and Lisata Therapeutics' $4.00 per share sale to Kuva Labs. The firm is examining potential securities law violations and breaches of fiduciary duties, seeking to determine if shareholders are receiv...
Class action law firm Monteverde & Associates PC announced investigations into several merger and acquisition transactions, including Lisata Therapeutics' sale to Smithfield Foods, Independent Bank Corporation's merger with HCB Financial Corp, and Sila Realty Trust's sale to Sunshine Ultimate Parent LLC. The firm is seeking shareholders who may h...
